Desiccated thyroid extract (DTE) and levothyroxine (T4) are both FDA-approved treatments for hypothyroidism — but they differ in hormone composition, conversion requirements, and patient experience. TelosRX compares both so you can have a more informed conversation with your provider.
The question "which is better?" doesn't have one answer. It depends on your thyroid function, genetics, symptoms, and how your body converts T4 into its active form. Both options have real evidence behind them — and real patients who do better on one versus the other.
Here's what the research actually shows on desiccated thyroid vs levothyroxine, and what the differences mean in practice.
The Core Difference: T4 Only vs T4 Plus T3
Thyroid hormone exists in two primary forms in the body:
- T4 (thyroxine): The storage form. Produced mainly by the thyroid gland; must be converted to T3 to become active.
- T3 (triiodothyronine): The active form. Directly binds thyroid receptors; drives metabolism, energy, and mood effects.
Levothyroxine provides only T4. Your body handles the conversion. Desiccated thyroid extract — sold as Armour Thyroid, NP Thyroid, and other brands — contains both T4 and T3 in a ratio derived from porcine (pig) thyroid gland. That distinction drives most of the practical differences below.
Head-to-Head Comparison
| Feature | Levothyroxine (T4 only) | Desiccated Thyroid Extract (DTE) |
|---|---|---|
| Hormone content | T4 only (synthetic) | T4 + T3 (natural ratio approximately 4:1) |
| Source | Synthetic | Porcine thyroid gland |
| FDA approval | Yes — hypothyroidism | Yes — hypothyroidism (commercial brands) |
| Guideline position | First-line recommended | Second-line; increasingly acknowledged as a valid option |
| T3 conversion required? | Yes — body converts T4 to T3 | No — T3 delivered directly |
| Serum T3 levels | Depends on conversion efficiency | 30–50% higher T3 vs levothyroxine monotherapy in some studies |
| Dosing predictability | Standardized, predictable | Standardized; T3 component requires closer monitoring |
| Patient preference | Preferred by roughly 50% in trials | Preferred by roughly 50% in trials; modest weight benefit in one RCT |
| Compounded option? | Custom T4 doses can be compounded | Custom T3/T4 ratios can be compounded (not FDA-approved as compounded) |
The Conversion Problem: Why Some People Feel Better on DTE
About 15% of hypothyroid patients on levothyroxine report persistent symptoms — fatigue, brain fog, weight gain — despite TSH levels in the normal range. Research has explored why.
One explanation: the DIO2 gene variant. This genetic polymorphism affects the enzyme that converts T4 into active T3 in peripheral tissues. People with this variant convert T4 less efficiently, meaning adequate serum T4 doesn't translate into adequate T3 where it's needed. Research published in JAMA has examined how DIO2 polymorphisms affect patient outcomes on levothyroxine therapy.
A 2021 comparative effectiveness study published in the Journal of the Endocrine Society found that while most patients responded similarly to levothyroxine or DTE, those most symptomatic on levothyroxine showed positive responses to DTE or combination T3/T4 therapy. Patient preference for DTE was observed in nearly 50% of trial participants — with modest weight reduction (roughly 4 lbs) observed on DTE in one randomized crossover study.
If you've been on levothyroxine and still feel unwell at a normal TSH, the conversion pathway is worth discussing with your provider. It's not a universal explanation, but it's a real clinical consideration. See our hormone optimization guide for how thyroid fits into a broader protocol review.
What T3 Differences Mean in Practice
DTE's T3 component acts faster and more directly than the T4-to-T3 conversion pathway. Some practical effects:
- Higher serum T3 on DTE — 30–50% above levothyroxine users in some studies
- More pronounced cardiovascular effects — monitoring is warranted at higher doses
- Some patients report improved energy, mood, and weight management on DTE
- DTE's T3 content can cause transient peaks; splitting doses (morning and midday) helps smooth the curve
Higher T3 is not automatically better. It requires careful monitoring to avoid hyperthyroid symptoms like palpitations, anxiety, or insomnia. This is one reason endocrinology guidelines default to levothyroxine — it's more predictable in population-level outcomes, even if some individuals do better on DTE or combination therapy.
Compounded Thyroid: A Third Option
Beyond branded DTE and synthetic T4, compounded thyroid preparations allow custom T3/T4 ratios — something neither standard DTE nor levothyroxine alone can offer. A compounded preparation might be appropriate when someone:
- Does poorly on available DTE brands
- Needs a ratio different from the fixed 4:1 T4:T3 in commercial DTE
- Requires dose precision not achievable with commercial tablets
- Has sensitivity to fillers in commercial formulations
Compounded thyroid formulations are not FDA-approved as compounded preparations (commercial DTE brands are FDA-approved; compounded versions are not). They are prepared subject to medical approval by a licensed provider following an asynchronous evaluation. Like TRT at TelosRX, thyroid support is reviewed as part of a broader hormone evaluation before any protocol is initiated.
Which Option Should You Consider?
There's no single correct choice. Here's a practical framework:
- Start with levothyroxine if you're newly diagnosed. It's well-studied, predictable, and the standard of care for a reason.
- Consider DTE or compounded T3/T4 if you've been on levothyroxine at adequate doses for 3–6 months and still have significant symptoms with normal TSH — particularly fatigue, weight management difficulty, or brain fog.
- Genetic testing for DIO2 variants can inform the conversation, though it's not yet standard practice.
- Any change in thyroid medication warrants careful lab monitoring (TSH, free T4, free T3) and provider supervision.
This is not a decision to make unilaterally from a blog post. If you're struggling on your current regimen, a provider evaluation — reviewing your symptoms, labs, and history — is the right first step. At TelosRX's hormone longevity program, evaluations are handled asynchronously, with a licensed provider reviewing your case before any protocol is issued, subject to medical approval by a licensed provider.
Frequently Asked Questions
Is desiccated thyroid better than levothyroxine?
Neither is universally better. Clinical trials show similar overall outcomes for most patients, but a meaningful subset — particularly those persistently symptomatic on levothyroxine — report preference and symptomatic improvement on DTE or combination T3/T4 therapy. A 2021 comparative effectiveness study confirmed this subset response. Appropriateness depends on your labs, symptoms, and medical history, evaluated by a licensed provider.
Why do some doctors not prescribe desiccated thyroid?
Major endocrinology guidelines have historically recommended levothyroxine as first-line therapy due to its predictability, standardized dosing, and extensive evidence base. DTE's T3 content requires closer monitoring. Views have evolved — some recent guidelines acknowledge DTE as a reasonable option for patients who don't respond adequately to T4 alone. The conversation is worth having with your provider.
What is the difference between T3 and T4?
T4 (thyroxine) is the storage form of thyroid hormone — relatively inactive until converted to T3 by enzymes in peripheral tissues. T3 (triiodothyronine) is the active form that directly binds thyroid hormone receptors and drives metabolic effects including energy regulation, temperature control, and mood. Levothyroxine provides T4; the body converts it. DTE provides both, bypassing conversion.
Can I switch from levothyroxine to desiccated thyroid?
Yes, but not without medical supervision. Switching requires dose recalculation (the milligram equivalence between T4 and DTE is not 1:1), and labs should be monitored 6–8 weeks after any change. Symptoms can fluctuate during the transition. This is a decision made with a provider following a full evaluation of your current labs, symptoms, and history, subject to medical approval by a licensed provider.
Is compounded thyroid medication an option?
Compounded thyroid preparations — custom T3/T4 ratios, specific fillers, dose precision — are available at LegitScript-certified compounding pharmacies like TelosRX, subject to provider evaluation and medical approval. They are not FDA-approved as compounded preparations. They may be appropriate when commercial DTE or levothyroxine doesn't meet clinical needs. Provider evaluation determines appropriateness on an individual basis.
How do I know if I need T3 in addition to T4?
Persistent symptoms on adequate levothyroxine therapy with normal TSH is the primary clinical signal. Labs that may support investigation include free T3 levels, reverse T3, and DIO2 genetic testing. None of these findings alone mandate combination therapy — the full picture is what a provider evaluates. Discuss your symptom pattern during an asynchronous evaluation rather than self-adjusting.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.